LHPP deficiency aggravates liver fibrosis through TGF‐β/Smad3 signaling
The FASEB Journal · 2024
DOI: 10.1096/fj.202400117rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Yue Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Ch…. Hauptthemen laut MEDLINE: Smad3 Protein, Liver Cirrhosis, Inorganic Pyrophosphatase, Mice, Knockout. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, "Gan-Po Talent 555" Project of Jiangxi Province, Postgraduate Innovation Special Foundation of Jiangxi Province.
Abstract (Originalsprache)
Liver fibrosis is characterized by a wound‐healing response and may progress to liver cirrhosis and even hepatocellular carcinoma. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) is a tumor suppressor that participates in malignant diseases. However, the role of LHPP in liver fibrosis has not been determined. Herein, the function and regulatory network of LHPP were explored in liver fibrosis. The expression of LHPP in human and murine fibrotic liver tissues was assessed via immunohistochemistry and Western blot analysis. In addition, liver fibrosis was induced in wild‐type (WT) and LHPP −/− (KO) mice after carbon tetrachloride (CCl 4 ) or thioacetamide (TAA) treatment. The effect of LHPP was systematically assessed by using specimens acquired from the above murine models. The functional role of LHPP was further explored by detecting the pathway activity of TGF‐β/Smad3 and apoptosis after interfering with LHPP in vitro. To explore whether the function of LHPP depended on the TGF‐β/Smad3 pathway in vivo, an inhibitor of the TGF‐β/Smad3 pathway was used in CCl 4 ‐induced WT and KO mice. LHPP expression was downregulated in liver tissue samples from fibrosis patients and fibrotic mice. LHPP deficiency aggravated CCl 4 ‐ and TAA‐induced liver fibrosis. Moreover, through immunoblot analysis, we identified the TGF‐β/Smad3 pathway as a key downstream pathway of LHPP in vivo and in vitro. The effect of LHPP deficiency was reversed by inhibiting the TGF‐β/Smad3 pathway in liver fibrosis. These results revealed that LHPP deficiency exacerbates liver fibrosis through the TGF‐β/Smad3 pathway. LHPP may be a potential therapeutic target in hepatic fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
ORCID-Profile: Yue Zhang, Bi-Min Li, Wang Zhang, Peng Chen, Linxiang Liu, Yuan Nie, Chenkai Huang, Xuan Zhu
Förderung
- National Natural Science Foundation of China
- "Gan-Po Talent 555" Project of Jiangxi Province
- Postgraduate Innovation Special Foundation of Jiangxi Province
- Jiangxi Provincial Natural Science Foundation
- Hospital Youth Talent Training Foundation
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Zhang, Y., Li, B. M., Zhang, W., Chen, P., Liu, L., Nie, Y., Huang, C., & Zhu, X. (2024). LHPP deficiency aggravates liver fibrosis through TGF‐β/Smad3 signaling. The FASEB Journal. https://doi.org/10.1096/fj.202400117rr
Vancouver
Zhang Y, Li BM, Zhang W, Chen P, Liu L, Nie Y, et al. LHPP deficiency aggravates liver fibrosis through TGF‐β/Smad3 signaling. The FASEB Journal. 2024. doi:10.1096/fj.202400117rr
BibTeX
@article{Zhang2024,
author = {Zhang, Yue and Li, Bi-Min and Zhang, Wang and Chen, Peng and Liu, Linxiang and Nie, Yuan and Huang, Chenkai and Zhu, Xuan},
title = {LHPP deficiency aggravates liver fibrosis through TGF‐β/Smad3 signaling},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400117rr}
}
EUVIMED